SEC Comment Letter 0000000000-23-008771 to Vaxxinity, Inc. (VAXX) (CIK 0001851657)
Vaxxinity, Inc. (VAXX) (CIK 0001851657)
Date: Aug. 11, 2023 · CIK: 0001851657 · Accession: 0000000000-23-008771
AI Filing Summary & Sentiment
File numbers found in text: 333-273822
Letter
United States securities and exchange commission logo August 11, 2023 Mei Mei Hu Chief Executive Officer Vaxxinity, Inc. 505 Odyssey Way Merritt Island, Florida 32953 Re:Vaxxinity, Inc. Registration Statement on Form S-3 Filed August 9, 2023 File No. 333-273822 Dear Mei Mei Hu: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jimmy McNamara at 202-551-7349 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Yasin Keshvargar
Show Raw Text
United States securities and exchange commission logo
August 11, 2023
Mei Mei Hu
Chief Executive Officer
Vaxxinity, Inc.
505 Odyssey Way
Merritt Island, Florida 32953
Re:Vaxxinity, Inc.
Registration Statement on Form S-3
Filed August 9, 2023
File No. 333-273822
Dear Mei Mei Hu:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jimmy McNamara at 202-551-7349 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Yasin Keshvargar